Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 132 articles:
HTML format
Text format



Single Articles


    February 2018
  1. SILVEIRA CRA, Roy EA, Almeida QJ
    Acute effects of aerobic exercise on cognitive function in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Feb 3. pii: S0304-3940(18)30068.
    PubMed     Text format     Abstract available


    January 2018
  2. MAO W, Zhao C, Ding H, Liang K, et al
    Pyrosequencing analysis of methylation levels of clock genes in leukocytes from Parkinson's disease patients.
    Neurosci Lett. 2018;668:115-119.
    PubMed     Text format     Abstract available


  3. WANG X, Li J, Wang M, Yuan Y, et al
    Alterations of the amplitude of low-frequency fluctuations in anxiety in Parkinson's disease.
    Neurosci Lett. 2018;668:19-23.
    PubMed     Text format     Abstract available


    December 2017
  4. SEKAR S, Taghibiglou C
    Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.
    Neurosci Lett. 2017;666:139-143.
    PubMed     Text format     Abstract available


  5. WANG L, Nie K, Zhao X, Feng S, et al
    Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31020.
    PubMed     Text format     Abstract available


  6. CHENG Y, Mao CY, Liu YT, Li F, et al
    Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: a case-control study and meta-analysis.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31018.
    PubMed     Text format     Abstract available


  7. HARRISON IF, Smith AD, Dexter DT
    Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
    Neurosci Lett. 2017;666:48-57.
    PubMed     Text format     Abstract available


  8. AN C, Pu X, Xiao W, Zhang H, et al
    Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017;665:236-239.
    PubMed     Text format     Abstract available


  9. BREZA M, Koutsis G, Karadima G, Potagas C, et al
    The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia.
    Neurosci Lett. 2017 Dec 9. pii: S0304-3940(17)30988.
    PubMed     Text format     Abstract available


    November 2017
  10. LI XR, Ren YD, Cao B, Huang XL, et al
    Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Neurosci Lett. 2017 Nov 30. pii: S0304-3940(17)30973.
    PubMed     Text format     Abstract available


  11. DU K, Liu MY, Pan YZ, Zhong X, et al
    Association of circulating manganese levels with Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017;665:92-98.
    PubMed     Text format     Abstract available


  12. CAI M, Liu Z, Li W, Wang Y, et al
    Association between rs823128 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017 Nov 27. pii: S0304-3940(17)30966.
    PubMed     Text format     Abstract available


  13. PAPAGIANNAKIS N, Koros C, Stamelou M, Simitsi AM, et al
    Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.
    Neurosci Lett. 2017 Nov 9. pii: S0304-3940(17)30910.
    PubMed     Text format     Abstract available


  14. YUAN XQ, Cao B, Wu Y, Chen YP, et al
    Association analysis of SNP rs11868035 in SREBF1 with sporadic Parkinson's disease, sporadic amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.
    Neurosci Lett. 2017 Nov 8. pii: S0304-3940(17)30913.
    PubMed     Text format     Abstract available


    October 2017
  15. LIU L, Zhang L, Guo L, Yu Q, et al
    MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.
    Neurosci Lett. 2017;662:339-345.
    PubMed     Text format     Abstract available


  16. WU Q, Gao Y, Liu AS, Xie LZ, et al
    Large-scale cortical volume correlation networks reveal disrupted small world patterns in Parkinson's disease.
    Neurosci Lett. 2017 Oct 20. pii: S0304-3940(17)30858.
    PubMed     Text format     Abstract available


  17. MATSUURA K, Kajikawa H, Tabei KI, Satoh M, et al
    The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson's disease.
    Neurosci Lett. 2017 Oct 12. pii: S0304-3940(17)30836.
    PubMed     Text format     Abstract available


    September 2017
  18. KONG P, Lei P, Zhang S, Li D, et al
    Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2017 Sep 28. pii: S0304-3940(17)30793.
    PubMed     Text format     Abstract available


  19. GMITTEROVA K, Gawinecka J, Heinemann U, Valkovic P, et al
    DNA versus RNA oxidation in Parkinson's disease: which is more important?
    Neurosci Lett. 2017 Sep 26. pii: S0304-3940(17)30790.
    PubMed     Text format     Abstract available


  20. ABBAOUI A, Chatoui H, Hiba OE, Gamrani H, et al
    Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Neurosci Lett. 2017 Sep 14. pii: S0304-3940(17)30774.
    PubMed     Text format     Abstract available


  21. XI J, Yang X, Zhao Q, Zheng J, et al
    Absence of association of the Ala58Val (rs17571) CTSD gene variant with Parkinson's disease or amyotrophic lateral sclerosis in a Han Chinese population.
    Neurosci Lett. 2017 Sep 13. pii: S0304-3940(17)30771.
    PubMed     Text format     Abstract available


  22. FLACH A, Jaegers L, Krieger M, Bixler E, et al
    Endurance Exercise Improves Function in Individuals with Parkinson's Disease: A Meta-analysis.
    Neurosci Lett. 2017 Sep 1. pii: S0304-3940(17)30733.
    PubMed     Text format     Abstract available


    August 2017
  23. CAO H, Shi J, Cao B, Kang B, et al
    Evaluation of the Braak staging of brain pathology with 1H-MRS in patients with Parkinson's disease.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30697.
    PubMed     Text format     Abstract available


  24. LINDENAU JD, Altmann V, Schumacher-Schuh AF, Rieder CR, et al
    Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30696.
    PubMed     Text format     Abstract available


  25. FANG J, Hou B, Liu H, Zhang X, et al
    Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017;658:102-107.
    PubMed     Text format     Abstract available


  26. LUDTMANN MHR, Abramov AY
    Mitochondrial calcium imbalance in Parkinson's disease.
    Neurosci Lett. 2017 Aug 21. pii: S0304-3940(17)30691.
    PubMed     Text format     Abstract available


  27. BERGE-SEIDL V, Pihlstrom L, Maple-Grodem J, Forsgren L, et al
    The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Neurosci Lett. 2017 Aug 19. pii: S0304-3940(17)30687.
    PubMed     Text format     Abstract available


  28. GAO Y, Nie K, Huang B, Mei M, et al
    Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Neurosci Lett. 2017 Aug 17. pii: S0304-3940(17)30675.
    PubMed     Text format     Abstract available


  29. LV W, Guan Q, Hu X, Chen J, et al
    Vestibulo-ocular reflex abnormality in Parkinson's disease detected by video head impulse test.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30668.
    PubMed     Text format     Abstract available


  30. HE T, Wang J, Wang X, Deng W, et al
    Association between PARK16 and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30669.
    PubMed     Text format     Abstract available


  31. XIAO H, Li M, Cai J, Li N, et al
    Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
    Neurosci Lett. 2017 Aug 10. pii: S0304-3940(17)30663.
    PubMed     Text format     Abstract available


  32. FANG J, Chen H, Cao Z, Jiang Y, et al
    Impaired Brain Network Architecture in Newly Diagnosed Parkinson's Disease Based on Graph Theoretical Analysis.
    Neurosci Lett. 2017 Aug 5. pii: S0304-3940(17)30638.
    PubMed     Text format     Abstract available


    July 2017
  33. RINGMAN JM, Casado M, Van Berlo V, Pa J, et al
    A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30618.
    PubMed     Text format     Abstract available


  34. WEILAN Y, Weiguo Y, Baisheng H, Lixiang W, et al
    Neuroprotective Effects of Lentivirus-mediated Cystathionine-beta-synthase Overexpression against 6-OHDA-induced Parkinson's Disease Rats.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30581.
    PubMed     Text format     Abstract available


  35. LI X, Xue L, Sun J, Sun Y, et al
    Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population.
    Neurosci Lett. 2017;656:72-76.
    PubMed     Text format     Abstract available


  36. REED-JONES RJ, Powell DW
    The effects of gaze stabilization on gait parameters in individuals with Parkinson's disease.
    Neurosci Lett. 2017 Jul 11. pii: S0304-3940(17)30573.
    PubMed     Text format     Abstract available


  37. YAO Z, Shao Y, Han X
    Freezing of gait is associated with cognitive impairment in patients with Parkinson disease.
    Neurosci Lett. 2017 Jul 8. pii: S0304-3940(17)30555.
    PubMed     Text format     Abstract available


    June 2017
  38. DIBILIO V, Nicoletti A, Mostile G, Portaro G, et al
    Computer-Assisted Cognitive Rehabilitation on Freezing of Gait in Parkinson's Disease: A Pilot Study.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30486.
    PubMed     Text format     Abstract available


  39. HE D, Hu P, Deng X, Song Z, et al
    Genetic analysis of the RIC3 gene in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30487.
    PubMed     Text format     Abstract available


  40. WANG X, Zhang J, Yuan Y, Li T, et al
    Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Neurosci Lett. 2017;653:202-207.
    PubMed     Text format     Abstract available


  41. SHIN JH, Shin SA, Lee JY, Nam H, et al
    Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Neurosci Lett. 2017;653:250-257.
    PubMed     Text format     Abstract available


    May 2017
  42. HAO Y, Shabanpoor A, Metz GA
    Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
    Neurosci Lett. 2017;651:79-87.
    PubMed     Text format     Abstract available


    April 2017
  43. PENG B, Wang S, Zhou Z, Liu Y, et al
    A multilevel-ROI-features-based machine learning method for detection of morphometric biomarkers in Parkinson's disease.
    Neurosci Lett. 2017 Apr 20. pii: S0304-3940(17)30335.
    PubMed     Text format     Abstract available


  44. LIU H, Liu H, Li T, Cui J, et al
    NR4A2 genetic variation and Parkinson's disease: evidence from a systematic review and meta-analysis.
    Neurosci Lett. 2017 Apr 3. pii: S0304-3940(17)30090.
    PubMed     Text format     Abstract available


  45. YANG X, Zheng J, An R, Tian S, et al
    Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2017 Apr 2. pii: S0304-3940(17)30287.
    PubMed     Text format     Abstract available


    March 2017
  46. CHEN S, Liu Y, Niu Y, Xu Y, et al
    Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients.
    Neurosci Lett. 2017 Mar 27. pii: S0304-3940(17)30275.
    PubMed     Text format     Abstract available


  47. KUMARI N, Agrawal S, Luthra PM
    Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in rodent model of haloperidol induced Parkinson like symptoms.
    Neurosci Lett. 2017;647:53-60.
    PubMed     Text format     Abstract available


  48. DEMETER G, Valalik I, Pajkossy P, Szollosi A, et al
    The effect of deep brain stimulation of the subthalamic nucleus on executive functions: Impaired verbal fluency and intact updating, planning and conflict resolution in Parkinson's disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30247.
    PubMed     Text format     Abstract available


  49. WANG L, Huang J, Pang S, Qin X, et al
    Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
    Neurosci Lett. 2017;646:30-35.
    PubMed     Text format     Abstract available


    February 2017
  50. TANG Y, Meng L, Wan CM, Liu ZH, et al
    Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals.
    Neurosci Lett. 2017 Feb 26. pii: S0304-3940(17)30172.
    PubMed     Text format     Abstract available


  51. CAO XY, Lu JM, Zhao ZQ, Li MC, et al
    MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Neurosci Lett. 2017 Feb 18. pii: S0304-3940(17)30161.
    PubMed     Text format     Abstract available


  52. TANAKA K, Miyake Y, Fukushima W, Kiyohara C, et al
    Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Neurosci Lett. 2017;643:97-102.
    PubMed     Text format     Abstract available


  53. FATHALLA AM, Soliman AM, Moustafa AA
    Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.
    Neurosci Lett. 2017;643:89-96.
    PubMed     Text format     Abstract available


  54. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Text format     Abstract available


  55. LI Y, Huang J, Pang S, Wang H, et al
    Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
    Neurosci Lett. 2017 Feb 13. pii: S0304-3940(17)30134.
    PubMed     Text format     Abstract available


  56. TIAN S, Yang X, Zhao Q, Zheng J, et al
    Association between a heme oxygenase-2 genetic variant and risk of Parkinson's disease in Han Chinese.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30114.
    PubMed     Text format     Abstract available


    January 2017
  57. KANG SY, Lee SB, Kim HJ, Kim HT, et al
    Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Neurosci Lett. 2017 Jan 27. pii: S0304-3940(17)30091.
    PubMed     Text format     Abstract available


  58. CORBILLE AG, Preterre C, Rolli-Derkinderen M, Coron E, et al
    Biochemical analysis of alpha-synuclein extracted from control and Parkinson's disease colonic biopsies.
    Neurosci Lett. 2017 Jan 23. pii: S0304-3940(17)30070.
    PubMed     Text format     Abstract available


  59. ZHANG Y, Wu JY, Weng LH, Li XX, et al
    Valproic acid protects against MPP(+)-mediated neurotoxicity in SH-SY5Y Cells through autophagy.
    Neurosci Lett. 2017;638:60-68.
    PubMed     Text format     Abstract available


  60. BRIFFA M, Ghio S, Neuner J, Gauci AJ, et al
    Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Neurosci Lett. 2017;638:12-20.
    PubMed     Text format     Abstract available


    December 2016
  61. PEZZI JC, Bem CM, Rocha TJ, Schumacher-Schuh AF, et al
    Association between DNA methyltransferase gene polymorphism and Parkinson's disease.
    Neurosci Lett. 2016 Dec 29. pii: S0304-3940(16)31006.
    PubMed     Text format     Abstract available


  62. RIAL D, Morato X, Real JI, Goncalves FQ, et al
    Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses.
    Neurosci Lett. 2016;638:162-166.
    PubMed     Text format     Abstract available


  63. XIANG Y, Gong T, Wu J, Li J, et al
    Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.
    Neurosci Lett. 2016;638:145-150.
    PubMed     Text format     Abstract available


    November 2016
  64. XIE Y, Feng H, Peng S, Xiao J, et al
    Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2016 Nov 10. pii: S0304-3940(16)30846.
    PubMed     Text format     Abstract available


  65. LATTARI E, Costa SS, Campos C, de Oliveira AJ, et al
    Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson's disease?
    Neurosci Lett. 2016 Nov 9. pii: S0304-3940(16)30861.
    PubMed     Text format     Abstract available


  66. CAO CY, Zeng K, Li DY, Zhan SK, et al
    Modulations on cortical oscillations by Subthalamic deep brain stimulation in patients with Parkinson disease: a MEG study.
    Neurosci Lett. 2016 Nov 3. pii: S0304-3940(16)30848.
    PubMed     Text format     Abstract available


    October 2016
  67. PCHELINA S, Emelyanov A, Baydakova G, Andoskin P, et al
    Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Neurosci Lett. 2016 Oct 22. pii: S0304-3940(16)30792.
    PubMed     Text format     Abstract available


  68. ABREU GM, Valenca DC, Campos M Junior, da Silva CP, et al
    Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Neurosci Lett. 2016;635:67-70.
    PubMed     Text format     Abstract available


  69. DENG X, Tang CY, Zhang J, Zhu L, et al
    The cortical thickness correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016;633:279-289.
    PubMed     Text format     Abstract available


  70. HOU Y, Luo C, Yang J, Song W, et al
    A resting-state fMRI study on early-stage drug-naive Parkinson's disease patients with drooling.
    Neurosci Lett. 2016 Oct 4. pii: S0304-3940(16)30749.
    PubMed     Text format     Abstract available


    September 2016
  71. ZENG W, Liu F, Wang Q, Wang Y, et al
    Parkinson's disease classification using gait analysis via deterministic learning.
    Neurosci Lett. 2016 Sep 27. pii: S0304-3940(16)30726.
    PubMed     Text format     Abstract available


  72. SHI C, Li F, Yang J, Zhang S, et al
    DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Sep 26. pii: S0304-3940(16)30727.
    PubMed     Text format     Abstract available


  73. DENG X, Li FJ, Tang CY, Zhang J, et al
    The cortical surface correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016 Sep 17. pii: S0304-3940(16)30707.
    PubMed     Text format     Abstract available


  74. MATSUURA K, Maeda M, Tabei KI, Umino M, et al
    A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.
    Neurosci Lett. 2016 Sep 9. pii: S0304-3940(16)30684.
    PubMed     Text format     Abstract available


    August 2016
  75. CEN L, Xiao Y, Wei L, Mo M, et al
    Association of DYRK1A polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Aug 18. pii: S0304-3940(16)30601.
    PubMed     Text format     Abstract available


    July 2016
  76. MCKEOWN B KIN MD, Peters RM, Pasman EP, McKeown MJ, et al
    Plantar cutaneous function in Parkinson's disease patients ON and OFF L-dopa.
    Neurosci Lett. 2016 Jul 14. pii: S0304-3940(16)30515.
    PubMed     Text format     Abstract available


  77. CROSIERS D, Verstraeten A, Wauters E, Engelborghs S, et al
    Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Neurosci Lett. 2016 Jul 7. pii: S0304-3940(16)30494.
    PubMed     Text format     Abstract available


    June 2016
  78. NAIR VD, Ge Y
    Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson's disease striatum.
    Neurosci Lett. 2016 Jun 28. pii: S0304-3940(16)30470.
    PubMed     Text format     Abstract available


  79. WU H, Lu X, Xie F, Cen Z, et al
    Genetic analysis of the CHCHD2 gene in a cohort of Chinese patients with Parkinson disease.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30463.
    PubMed     Text format     Abstract available


  80. LI XY, Teng JJ, Liu Y, Wu YB, et al
    Association of AKT1 Gene Polymorphisms with Sporadic Parkinson's disease in Chinese Han Population.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30461.
    PubMed     Text format     Abstract available


  81. LU Q, Song Z, Deng X, Xiong W, et al
    SLC6A3 rs28363170 and rs3836790 variants in Han Chinese patients with sporadic Parkinson's disease.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30462.
    PubMed     Text format     Abstract available


  82. KANG SY, Park S, Oh E, Park J, et al
    Vitamin D receptor polymorphisms and Parkinson's disease in a Korean population: Revisited.
    Neurosci Lett. 2016 Jun 21. pii: S0304-3940(16)30450.
    PubMed     Text format     Abstract available


  83. SHIN MS, Jeong HY, An DI, Lee HY, et al
    Corrigendum to "Treadmill exercise facilitates synaptic plasticity on dopaminergic neurons and fibers in the mouse model with Parkinson's disease" [Neurosci. Lett. (2016) 28-33].
    Neurosci Lett. 2016 Jun 20. pii: S0304-3940(16)30328.
    PubMed     Text format    


  84. BHATTACHARJEE N, Khairujjaman Mazumder M, Paul R, Choudhury A, et al
    L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra.
    Neurosci Lett. 2016 Jun 6. pii: S0304-3940(16)30410.
    PubMed     Text format     Abstract available


  85. TARD C, Devanne H, Defebvre L, Delval A, et al
    Single session intermittent theta-burst stimulation on the left premotor cortex does not alleviate freezing of gait in Parkinson's disease.
    Neurosci Lett. 2016 Jun 3. pii: S0304-3940(16)30391.
    PubMed     Text format     Abstract available


    May 2016
  86. GEBREMEDHIN KG, Rademacher DJ
    Histone H3 Acetylation in the Postmortem Parkinson's Disease Primary Motor Cortex.
    Neurosci Lett. 2016 May 27. pii: S0304-3940(16)30390.
    PubMed     Text format     Abstract available


  87. GULLY JC, Sergeyev VG, Bhootada Y, Mendez-Gomez H, et al
    Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson's disease.
    Neurosci Lett. 2016 May 24. pii: S0304-3940(16)30359.
    PubMed     Text format     Abstract available


  88. SWANK C, Mehta J, Criminger C
    Transcranial Direct Current Stimulation Lessens Dual Task Cost in People with Parkinson's Disease.
    Neurosci Lett. 2016 May 12. pii: S0304-3940(16)30309.
    PubMed     Text format     Abstract available


  89. CHEN H, Huang X, Yuan L, Xia H, et al
    A homozygous parkin p.G284R mutation in a Chinese family with autosomal recessive juvenile parkinsonism.
    Neurosci Lett. 2016 May 10. pii: S0304-3940(16)30310.
    PubMed     Text format     Abstract available


    April 2016
  90. WANG X, Zhang X, Xue L, Xie A, et al
    The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis.
    Neurosci Lett. 2016 Apr 28. pii: S0304-3940(16)30278.
    PubMed     Text format     Abstract available


  91. SOLIMAN AM, Fathalla AM, Moustafa AA
    Dose-Dependent Neuroprotective Effect of Caffeineon a Rotenone-Induced Rat Model of Parkinsonism: A histological study.
    Neurosci Lett. 2016 Apr 27. pii: S0304-3940(16)30279.
    PubMed     Text format     Abstract available


  92. XU Y, Chen Y, Ou R, Wei QQ, et al
    No association of GPNMB rs156429 polymorphism with Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population.
    Neurosci Lett. 2016;622:113-117.
    PubMed     Text format     Abstract available


  93. FAN K, Tang BS, Wang YQ, Kang JF, et al
    The GBA, DYRK1A and MS4A6A polymorphisms influence the age at onset of Chinese Parkinson patients.
    Neurosci Lett. 2016;621:133-136.
    PubMed     Text format     Abstract available


  94. SHIN MS, Jeong HY, An DI, Lee HY, et al
    Treadmill exercise facilitates synaptic plasticity on dopaminergic neurons and fibers in the mouse model with Parkinson's disease.
    Neurosci Lett. 2016 Apr 11. pii: S0304-3940(16)30220.
    PubMed     Text format     Abstract available


  95. KELM-NELSON CA, Stevenson SA, Ciucci MR
    Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.
    Neurosci Lett. 2016 Apr 4. pii: S0304-3940(16)30208.
    PubMed     Text format     Abstract available


    March 2016
  96. TANIK N, Serin HI, Celikbilek A, Inan LE, et al
    Associations of olfactory bulb and depth of olfactory sulcus with basal ganglia and hippocampus in patients with Parkinson's disease.
    Neurosci Lett. 2016;620:111-114.
    PubMed     Text format     Abstract available


  97. VAN DER MERWE C, Carr J, Glanzmann B, Bardien S, et al
    Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
    Neurosci Lett. 2016 Mar 18. pii: S0304-3940(16)30166.
    PubMed     Text format     Abstract available


  98. MITRA S, Ghosh N, Sinha P, Chakrabarti N, et al
    Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Neurosci Lett. 2016;616:86-92.
    PubMed     Text format     Abstract available


    February 2016
  99. EMAMZADEH FN, Aojula H, McHugh P, Allsop D, et al
    Effects of different isoforms of apoE on aggregation of the alpha-synuclein protein implicated in Parkinson's disease.
    Neurosci Lett. 2016 Feb 24. pii: S0304-3940(16)30108.
    PubMed     Text format     Abstract available


  100. FARIAS CC, Maes M, Bonifacio KL, Bortolasci CC, et al
    Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: disease and staging biomarkers and new drug targets.
    Neurosci Lett. 2016 Feb 6. pii: S0304-3940(16)30078.
    PubMed     Text format     Abstract available


    January 2016
  101. GUO Z, Xu S, Du N, Liu J, et al
    Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: involvement of the dopamine system.
    Neurosci Lett. 2016 Jan 28. pii: S0304-3940(16)30047.
    PubMed     Text format     Abstract available


  102. TOUCHETTE JC, Breckenridge JM, Wilken GH, Macarthur H, et al
    Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.
    Neurosci Lett. 2016;612:178-84.
    PubMed     Text format     Abstract available


  103. POLNER B, Moustafa AA, Nagy H, Takats A, et al
    Dopamine improves exploration after expectancy violations and induces psychotic-like experiences in patients with Parkinson's disease.
    Neurosci Lett. 2016 Jan 25. pii: S0304-3940(16)30037.
    PubMed     Text format     Abstract available


  104. YALCINKAYA N, Haytural H, Bilgic B, Ozdemir O, et al
    Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30028.
    PubMed     Text format     Abstract available


  105. YUAN L, Song Z, Deng X, Xiong W, et al
    Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson's disease patients.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30030.
    PubMed     Text format     Abstract available


  106. ALTMANN V, Schumacher-Schuh AF, Rieck M, Callegari-Jacques SM, et al
    Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30029.
    PubMed     Text format     Abstract available


    December 2015
  107. ZHANG J, Yang B, Sun H, Zhou Y, et al
    Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Neurosci Lett. 2015 Dec 31. pii: S0304-3940(15)30348.
    PubMed     Text format     Abstract available


  108. CHEN FX, Kang DZ, Chen FY, Liu Y, et al
    Grey Matter Atrophy Associated With Mild Cognitive Impairment in Parkinson's Disease.
    Neurosci Lett. 2015 Dec 29. pii: S0304-3940(15)30346.
    PubMed     Text format     Abstract available


  109. HARRISON IF, Anis HK, Dexter DT
    Associated Degeneration of Ventral Tegmental Area Dopaminergic Neurons in the Rat Nigrostriatal Lactacystin Model of Parkinsonism and their Neuroprotection by Valproate.
    Neurosci Lett. 2015 Dec 29. pii: S0304-3940(15)30343.
    PubMed     Text format     Abstract available


  110. XU J, Zhang J, Wang J, Li G, et al
    Abnormal fronto-striatal functional connectivity in Parkinson's disease.
    Neurosci Lett. 2015 Dec 24. pii: S0304-3940(15)30336.
    PubMed     Text format     Abstract available


  111. TAN T, Song Z, Yuan L, Xiong W, et al
    Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015;612:189-192.
    PubMed     Text format     Abstract available


    November 2015
  112. HE S, Tan T, Song Z, Yuan L, et al
    Genetic analysis of MC1R variants in Chinese Han patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015 Nov 25. pii: S0304-3940(15)30271.
    PubMed     Text format     Abstract available


  113. TOROK R, Zadori D, Torok N, Csility E, et al
    An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015 Nov 4. pii: S0304-3940(15)30238.
    PubMed     Text format     Abstract available


    October 2015
  114. NAKASO K, Horikoshi Y, Takahashi T, Hanaki T, et al
    Estrogen receptor-mediated effect of delta-tocotrienol prevents neurotoxicity and motor deficit in the MPTP mouse model of Parkinson's disease.
    Neurosci Lett. 2015 Oct 30. pii: S0304-3940(15)30225.
    PubMed     Text format     Abstract available


  115. SCHIENLE A, Ille R, Wabnegger A
    Experience of negative emotions in Parkinson's disease: an fMRI investigation.
    Neurosci Lett. 2015 Oct 21. pii: S0304-3940(15)30209.
    PubMed     Text format     Abstract available


  116. KALINDERI K, Bostantjopoulou S, Katsarou Z, Dimikiotou M, et al
    D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.
    Neurosci Lett. 2015;606:113-6.
    PubMed     Text format     Abstract available


  117. CARVALHO DZ, Schonwald SV, Schumacher-Schuh AF, Braga CW, et al
    Overnight S100B in Parkinson's Disease: A glimpse into sleep-related neuroinflammation.
    Neurosci Lett. 2015 Oct 7. pii: S0304-3940(15)30173.
    PubMed     Text format     Abstract available


    September 2015
  118. ARIZA D, Lopes FN, Crestani CC, Martins-Pinge MC, et al
    CHEMOREFLEX AND BAROREFLEX ALTERATIONS IN PARKINSONISM INDUCED BY 6-OHDA IN UNANESTHETIZED RATS.
    Neurosci Lett. 2015 Sep 23. pii: S0304-3940(15)30150.
    PubMed     Text format     Abstract available


    August 2015
  119. GU C, Shen T, An H, Yuan C, et al
    Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
    Neurosci Lett. 2015 Aug 18. pii: S0304-3940(15)30089.
    PubMed     Text format     Abstract available


  120. ALDECOA I, Navarro-Otano J, Stefanova N, Sprenger FS, et al
    Alpha-synuclein immunoreactivity patterns in the enteric nervous system.
    Neurosci Lett. 2015;602:145-9.
    PubMed     Text format     Abstract available


  121. HALDER T, Raj J, Sharma V, Das P, et al
    Novel P-TEN-induced putative kinase 1 (PINK1) variant in Indian Parkinson's disease Patient.
    Neurosci Lett. 2015 Aug 14. pii: S0304-3940(15)30091.
    PubMed     Text format     Abstract available


  122. GUO JF, Dong XL, Xu Q, Li N, et al
    Exon dosage analysis of parkin gene in Chinese sporadic Parkinson's disease.
    Neurosci Lett. 2015 Aug 1. pii: S0304-3940(15)30066.
    PubMed     Text format     Abstract available


    July 2015
  123. ZHANG X, Niu M, Li H, Xie A, et al
    RIT2 rs12456492 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2015 Jul 15. pii: S0304-3940(15)30024.
    PubMed     Text format     Abstract available


  124. BRENNER S, Wersinger C, Gasser T
    Transcriptional regulation of the alpha-synuclein gene in human brain tissue.
    Neurosci Lett. 2015;599:140-5.
    PubMed     Text format     Abstract available


    June 2015
  125. PAN X, Chen C, Huang J, Wei H, et al
    Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Neurosci Lett. 2015 Jun 20. pii: S0304-3940(15)00473.
    PubMed     Text format     Abstract available


  126. WEN P, Li M, Xiao H, Ding R, et al
    Low-frequency stimulation of the pedunculopontine nucleus affects gait and the neurotransmitter level in the ventrolateral thalamic nucleus in 6-OHDA Parkinsonian rats.
    Neurosci Lett. 2015 Jun 5. pii: S0304-3940(15)00435.
    PubMed     Text format     Abstract available


    May 2015
  127. CIURLEO R, Bonanno L, Lorenzo GD, Bramanti P, et al
    Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
    Neurosci Lett. 2015 May 22. pii: S0304-3940(15)00409.
    PubMed     Text format     Abstract available


  128. WANG X, Yu S, Li F, Feng T, et al
    Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Neurosci Lett. 2015 May 18. pii: S0304-3940(15)00387.
    PubMed     Text format     Abstract available


  129. WANG S, Xu YF, Ding XY, Liu ZR, et al
    Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2015 May 15. pii: S0304-3940(15)00383.
    PubMed     Text format     Abstract available


  130. PREMA A, Janakiraman U, Manivasagam T, Thenmozhi AJ, et al
    Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice.
    Neurosci Lett. 2015 May 14. pii: S0304-3940(15)00381.
    PubMed     Text format     Abstract available


    February 2015
  131. ASANO T, Koike M, Sakata S, Takeda Y, et al
    Possible involvement of iron-induced oxidative insults in neurodegeneration.
    Neurosci Lett. 2015;588:29-35.
    PubMed     Text format     Abstract available


    January 2015
  132. WIEMERSLAGE L, Lee D
    Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and neuroprotection.
    Neurosci Lett. 2015;584:342-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: